SHL Telemedicine Ltd ADR - New SHLT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHLT is a good fit for your portfolio.
News
-
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
-
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
-
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
-
SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
-
Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24
Trading Information
- Previous Close Price
- $5.22
- Day Range
- $5.43–5.68
- 52-Week Range
- $4.86–12.75
- Bid/Ask
- $5.21 / $5.55
- Market Cap
- $91.02 Mil
- Volume/Avg
- 471 / 3,655
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 583
- Website
- https://www.shl-telemedicine.com
Comparables
Valuation
|
Metric
|
SHLT
|
INMD
|
NVLG
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 6.78 | 48.82 |
Price/Book Value | 1.26 | 1.82 | 2.22 |
Price/Sales | 1.59 | 2.97 | 0.50 |
Price/Cash Flow | — | 6.70 | 12.18 |
Price/Earnings
SHLT
INMD
NVLG
Financial Strength
|
Metric
|
SHLT
|
INMD
|
NVLG
|
|---|---|---|---|
Quick Ratio | 2.05 | 12.24 | 0.85 |
Current Ratio | 2.30 | 13.18 | 0.96 |
Interest Coverage | −4.42 | — | 0.20 |
Quick Ratio
SHLT
INMD
NVLG
Profitability
|
Metric
|
SHLT
|
INMD
|
NVLG
|
|---|---|---|---|
Return on Assets (Normalized) | — | 29.90% | 0.52% |
Return on Equity (Normalized) | — | 33.22% | 3.46% |
Return on Invested Capital (Normalized) | — | 30.04% | 2.29% |
Return on Assets
SHLT
INMD
NVLG
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Kkbbxfq | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Jsvdqwrf | Xtwv | $32.4 Bil | |
SOLV
| Solventum Corp | — | Gmpkwm | $11.1 Bil | |
MTHRF
| M3 Inc | — | Gdgjsvy | $8.2 Bil | |
MTHRY
| M3 Inc ADR | — | Nmlcnv | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Dhrkdf | $7.5 Bil | |
HQY
| HealthEquity Inc | — | Dmyxcf | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Rbykh | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Vdhcsp | $4.4 Bil | |
EVH
| Evolent Health Inc Class A | — | Ykzzr | $3.3 Bil |